These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 9766645)
1. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Liu XH; Yao S; Kirschenbaum A; Levine AC Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645 [TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664 [TBL] [Abstract][Full Text] [Related]
3. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Ding XZ; Tong WG; Adrian TE Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335 [TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells. Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848 [TBL] [Abstract][Full Text] [Related]
5. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747 [TBL] [Abstract][Full Text] [Related]
6. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells. Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416 [TBL] [Abstract][Full Text] [Related]
8. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. Liu X; Yue P; Zhou Z; Khuri FR; Sun SY J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759 [TBL] [Abstract][Full Text] [Related]
9. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression. Liu QY; Stein CA Clin Cancer Res; 1997 Nov; 3(11):2039-46. PubMed ID: 9815595 [TBL] [Abstract][Full Text] [Related]
10. Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells. Munkarah AR; Morris R; Baumann P; Deppe G; Malone J; Diamond MP; Saed GM J Soc Gynecol Investig; 2002; 9(3):168-73. PubMed ID: 12009392 [TBL] [Abstract][Full Text] [Related]
11. Dihydrotestosterone (DHT) modulates the ability of NSAIDs to induce apoptosis of prostate cancer cells. Andrews P; Krygier S; Djakiew D Cancer Chemother Pharmacol; 2002 Mar; 49(3):179-86. PubMed ID: 11935209 [TBL] [Abstract][Full Text] [Related]
12. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study]. Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595 [TBL] [Abstract][Full Text] [Related]
13. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687 [TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells. Li M; Wu X; Xu XC Int J Cancer; 2001 Jul; 93(2):218-23. PubMed ID: 11410869 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma; relationship to apoptosis and Bcl-2 protein expression. Tanji N; Kikugawa T; Yokoyama M Anticancer Res; 2000; 20(4):2313-9. PubMed ID: 10953290 [TBL] [Abstract][Full Text] [Related]
16. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126. Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831 [TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1. Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912 [TBL] [Abstract][Full Text] [Related]
18. COX-2 regulates p53 activity and inhibits DNA damage-induced apoptosis. Choi EM; Heo JI; Oh JY; Kim YM; Ha KS; Kim JI; Han JA Biochem Biophys Res Commun; 2005 Mar; 328(4):1107-12. PubMed ID: 15707991 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Elder DJ; Halton DE; Hague A; Paraskeva C Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550 [TBL] [Abstract][Full Text] [Related]
20. Resistance of prostate cancer cell lines to COX-2 inhibitor treatment. Wagner M; Loos J; Weksler N; Gantner M; Corless CL; Barry JM; Beer TM; Garzotto M Biochem Biophys Res Commun; 2005 Jul; 332(3):800-7. PubMed ID: 15907789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]